Publications

Download publications: 
Expand all
2019
  • Metwally, M., Bayoumi, A., Romero-Gomez, M., Thabet, K., John, M., Adams, L., Huo, X., Aller, R., Garcia-Monzon, C., Arias-Loste, M., Liddle, C., Qiao, L., George, J., Eslam, M., et al (2019). A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. Journal of Hepatology. 70 (3) , 494-500. [More Information]
  • Metwally, M., Bayoumi, A., Romero-Gomez, M., Thabet, K., John, M., Adams, L., Huo, X., Aller, R., Garcia-Monzon, C., Arias-Loste, M., Liddle, C., Qiao, L., George, J., Eslam, M., et al (2019). A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. Journal of Hepatology. 70 (3) , 494-500. [More Information]
  • El Sharkawy, R., Bayoumi, A., Metwally, M., Mangia, A., Berg, T., Romero-Gomez, M., Abate, M., Irving, W., Sheridan, D., Dore, G., Latchoumanin, O., Thabet, K., Najim, M., Douglas, M., Liddle, C., Qiao, L., George, J., Eslam, M., et al (2019). A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Scientific Reports. 9 (1) , 1-10. [More Information]

    Show 7 more
  • El Sharkawy, R., Bayoumi, A., Metwally, M., Mangia, A., Berg, T., Romero-Gomez, M., Abate, M., Irving, W., Sheridan, D., Dore, G., Latchoumanin, O., Thabet, K., Najim, M., Douglas, M., Liddle, C., Qiao, L., George, J., Eslam, M., et al (2019). A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Scientific Reports. 9 (1) , 1-10. [More Information]
  • Xu, K., Zhao, X., Fu, X., Xu, K., Li, Z., Miao, L., Li, Y., Cai, Z., Qiao, L., Bao, J. (2019). Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. Biomedicine and Pharmacotherapy. 117 [More Information]
  • John, M., Kim, K., Bae, S., Qiao, L., George, J. (2019). Role of BMP-9 in human liver disease. Gut. 68 (11) , 2097-2100. [More Information]
  • John, M., Kim, K., Bae, S., Qiao, L., George, J. (2019). Role of BMP-9 in human liver disease. Gut. 68 (11) , 2097-2100. [More Information]
  • Walker, S., Wankell, M., Ho, V., White, R., Deo, N., Devine, C., Dewdney, B., Bhathal, P., Govaere, O., Roskams, T., Qiao, L., George, J., Hebbard, L. (2019). Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model. PloS One. 14 (2) , e0212860. [More Information]
  • Walker, S., Wankell, M., Ho, V., White, R., Deo, N., Devine, C., Dewdney, B., Bhathal, P., Govaere, O., Roskams, T., Qiao, L., George, J., Hebbard, L. (2019). Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model. PloS One. 14 (2) , e0212860. [More Information]
  • Xu, K., Liu, S., Zhao, X., Zhang, X., Fu, X., Zhou, Y., Xu, K., Miao, L., Li, Z., Li, Y., Qiao, L., et al (2019). Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. Biomedicine and Pharmacotherapy. 110 , 844-849. [More Information]

2018
  • Zhou, G., Latchoumanin, O., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2018). Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers. Advanced Drug Delivery Reviews. 134 , 107-121. [More Information]
  • Zhou, G., Latchoumanin, O., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2018). Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers. Advanced Drug Delivery Reviews. 134 , 107-121. [More Information]
  • Zhang, J., Su, G., Tang, Z., Wang, L., Fu, W., Zhao, S., Ba, Y., Bai, B., Yue, P., Lin, Y., Qiao, L., et al (2018). Curcumol exerts anticancer effect in cholangiocarcinoma cells via down-regulating CDKL3. Frontiers in Physiology. 9 (MAR) [More Information]

    Show 7 more
  • Wu, T., Wang, C., Wang, W., Hui, Y., Zhang, R., Qiao, L., Dai, Y. (2018). Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis. OncoImmunology. 7 (11) , e1498437-1-e1498437-11. [More Information]
  • Pu, C., Huang, H., Wang, Z., Zou, W., Lv, Y., Zhou, Z., Zhang, Q., Qiao, L., Wu, F., Shao, S. (2018). Extracellular vesicle-associated mir-21 and mir-144 are markedly elevated in serum of patients with hepatocellular carcinoma. Frontiers in Physiology. 9 (JUL) , 1-8. [More Information]
  • Pu, C., Huang, H., Wang, Z., Zou, W., Lv, Y., Zhou, Z., Zhang, Q., Qiao, L., Wu, F., Shao, S. (2018). Extracellular vesicle-associated mir-21 and mir-144 are markedly elevated in serum of patients with hepatocellular carcinoma. Frontiers in Physiology. 9 , 1-8. [More Information]
  • Yuan, H., Chen, Z., Bai, S., Wei, H., Wang, Y., Ji, R., Guo, Q., Li, Q., Ye, Y., Wu, J., Qiao, L., et al (2018). Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. Cancer Letters. 418 , 84-96. [More Information]
  • Alzahrani, B., Iseli, T., Ramezani-Moghadam, M., Ho, V., Wankell, M., Sun, E., Qiao, L., George, J., Hebbard, L. (2018). The role of AdipoR1 and AdipoR2 in liver fibrosis. Biochimica et Biophysica Acta: international journal of biochemistry and biophysics. 1864 (3) , 700-708. [More Information]
  • Alzahrani, B., Iseli, T., Ramezani-Moghadam, M., Ho, V., Wankell, M., Sun, E., Qiao, L., George, J., Hebbard, L. (2018). The role of AdipoR1 and AdipoR2 in liver fibrosis. Biochimica et Biophysica Acta: international journal of biochemistry and biophysics. 1864 (3) , 700-708. [More Information]
  • Xu, K., Liu, S., Zhao, X., Zhang, X., Fu, X., Zhou, Y., Xu, K., Miao, L., Li, Z., Li, Y., Qiao, L., et al (2018). Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol. Biomedicine and Pharmacotherapy. 110 , 844-849. [More Information]

2017
  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et al (2017). Adiponectin confers protection from acute colitis and restricts a B cell immune response. Journal of Biological Chemistry. 292 (16) , 6569-6582. [More Information]
  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et al (2017). Adiponectin confers protection from acute colitis and restricts a B cell immune response. Journal of Biological Chemistry. 292 (16) , 6569-6582. [More Information]
  • Peng, M., Zhang, Q., Cheng, Y., Fu, S., Yang, H., Gou, X., Zhang, J., Wang, L., Zhang, L., Xue, Z., Qiao, L., et al (2017). Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression. Oncotarget. 8 (59) , 99693-99706. [More Information]

    Show 14 more
  • Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2017). Aptamer-based therapeutic approaches to target cancer stem cells. Theranostics. 7 (16) , 3948-3961. [More Information]
  • Zhou, G., Latchoumanin, O., Bagdesar, M., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2017). Aptamer-based therapeutic approaches to target cancer stem cells. Theranostics. 7 (16) , 3948-3961. [More Information]
  • Huo, X., Han, S., Wu, G., Latchoumanin, O., Zhou, G., Hebbard, L., George, J., Qiao, L. (2017). Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: Implications for tumorigenesis, disease progression, and liver cancer stem cells. Molecular Cancer. 16 (1) [More Information]
  • Huo, X., Han, S., Wu, G., Latchoumanin, O., Zhou, G., Hebbard, L., George, J., Qiao, L. (2017). Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: Implications for tumorigenesis, disease progression, and liver cancer stem cells. Molecular Cancer. 16 (1) [More Information]
  • Yan, S., Fan, J., Qiao, L. (2017). Hepatitis B virus (HBV) infection and hepatocellular carcinoma- New insights for an old topic. Current Cancer Drug Targets. 17 (6) , 505-511. [More Information]
  • Li, J., Zhou, Z., Zhang, X., Zheng, L., He, D., Ye, Y., Zhang, Q., Qi, C., He, X., Qiao, L., et al (2017). Inflammatory molecule, PSGL-1, deficiency activates macrophages to promote colorectal cancer growth through NFKB signaling. Molecular Cancer Research. 15 (4) , 467-477. [More Information]
  • Cai, Z., Xu, K., Li, Y., Bao, J., Qiao, L. (2017). Long noncoding RNA in liver cancer stem cells. Discovery Medicine. 24 (131) , 87-93.
  • Bao, J., Qiao, L. (2017). New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy. Cancer Letters. 387 , 1-2. [More Information]
  • Wu, G., Wilson, G., George, J., Liddle, C., Hebbard, L., Qiao, L. (2017). Overcoming treatment resistance in cancer: Current understanding and tactics. Cancer Letters. 387 , 69-76. [More Information]
  • Wu, G., Wilson, G., George, J., Liddle, C., Hebbard, L., Qiao, L. (2017). Overcoming treatment resistance in cancer: Current understanding and tactics. Cancer Letters. 387 , 69-76. [More Information]
  • Han, S., Latchoumanin, O., Wu, G., Zhou, G., Hebbard, L., George, J., Qiao, L. (2017). Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Cancer Letters. 390 , 188-200. [More Information]
  • Kong, L., Lu, Y., Zhang, S., Nan, Y., Qiao, L. (2017). Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. Discovery Medicine. 24 (131) , 95-106.
  • Fu, N., Yao, H., Nan, Y., Qiao, L. (2017). Role of oxidative stress in Hepatitis C Virus induced hepatocellular carcinoma. Current Cancer Drug Targets. 17 (6) , 498-504.
  • Huang, B., Yang, H., Cheng, X., Wang, D., Fu, S., Shen, W., Zhang, Q., Zhang, L., Xue, Z., Qiao, L., et al (2017). TRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer. Cancer Research. 77 (12) , 3194-3206. [More Information]

2016
  • Liu, X., Yang, Z., Latchoumanin, O., Qiao, L. (2016). Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer. Therapeutic Advances in Gastroenterology. 9 (6) , 853-860. [More Information]
  • Zhou, G., Wilson, G., Hebbard, L., Duan, W., Liddle, C., George, J., Qiao, L. (2016). Aptamers: A promising chemical antibody for cancer therapy. Oncotarget. 7 (12) , 13446-13463. [More Information]
  • Lu, H., Wang, J., Wang, Y., Qiao, L., Zhou, Y. (2016). Embelin and its role in chronic diseases. Advances in Experimental Medicine and Biology: Anti-inflammatory Nutraceuticals and Chronic Diseases. 928 , 397-418. [More Information]

    Show 9 more
  • Charrez, B., Qiao, L., Hebbard, L. (2016). Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. World Journal of Gastroenterology. 22 (8) , 2494-2502. [More Information]
  • Meng, P., Zhao, S., Niu, X., Fu, N., Su, S., Wang, R., Zhang, Y., Qiao, L., Nan, Y. (2016). Involvement of the interleukin-23/interleukin-17 axis in chronic hepatitis C virus infection and its treatment responses. International Journal of Molecular Sciences. 17 (7) , 1-15. [More Information]
  • Wu, T., Dai, Y., Wang, W., Teng, G., Jiao, H., Shuai, X., Zhang, R., Zhao, P., Qiao, L. (2016). Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer. Oncotarget. 7 (15) , 19548-19558. [More Information]
  • Huang, B., Cheng, X., Wang, H., Huang, W., Ga Hu, Z., Wang, D., Zhang, K., Zhang, H., Xue, Z., Qiao, L., et al (2016). Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. Journal of Translational Medicine. 14 (1) , 1-12. [More Information]
  • Liu, J., Pu, C., Lang, L., Qiao, L., Abdullahi, M., Jiang, C. (2016). Molecular pathogenesis of hereditary hemochromatosis. Histology and histopathology. 31 (8) , 833-840. [More Information]
  • Wang, H., Zhang, H., Zhang, Y., Wang, D., Cheng, X., Yang, F., Zhang, Q., Xue, Z., Li, Y., Qiao, L., et al (2016). Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget. 7 (50) , 82864-82875. [More Information]
  • Li, Y., Qiao, L. (2016). Role of cancer stem cells in common gastrointestinal cancers: From pathogenesis to therapeutic targets. Current Stem Cell Research & Therapy. 11 (5) , 426-426.
  • Fu, N., Niu, X., Wang, Y., Du, H., Wang, B., Du, J., Li, Y., Wang, R., Zhang, Y., Qiao, L., et al (2016). Role of LncRNA-activated by transforming growth factor beta in the progression of hepatitis C virus-related liver fibrosis. Discovery Medicine. 22 (119)
  • Meng, W., Li, Y., Bai, B., Bai, Z., Yue, P., Li, X., Qiao, L. (2016). The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma. Discovery Medicine. 21 (118) , 489-494.

2015
  • Chang, J., Lan, T., Li, C., Ji, X., Zheng, L., Gou, H., Ou, Y., Wu, T., Qi, C., Qiao, L., et al (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. Journal of Hepatology. 63 (6) , 1413-1420. [More Information]
  • Ramezani-Moghadam, M., Wang, J., Ho, V., Iseli, T., Alzahrani, B., Xu, A., van der Poorten, D., Qiao, L., George, J., Hebbard, L. (2015). Adiponectin Reduces Hepatic Stellate Cell Migration by Promoting Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Secretion. The Journal of Biological Chemistry. 290 (9) , 5533-5542. [More Information]
  • Xiang, D., Shigdar, S., Qiao, G., Zhou, S., Li, Y., Wei, M., Qiao, L., Al Shamaileh, H., Zhu, Y., Zheng, C., et al (2015). Aptamer-mediated cancer gene therapy. Current Gene Therapy: the international journal for in-depth reviews on gene therapy. 15 (2) , 109-119.

    Show 19 more
  • Wang, Z., Zhou, W., Zhang, H., Qiao, L. (2015). Combination of Anti-Angiogenesis Agents and Transarterial Embolization: Is it a Promising Approach for the Treatment of Liver Cancer?. Discovery Medicine. 20 (108) , 51-55.
  • Wilson, G., Hebbard, L., Duan, W., Qiao, L., George, J. (2015). Editorial: Gene therapy for gastrointestinal and liver cancers: past experience, current status and future perspectives. Current Gene Therapy. 15 (2) , 93-96.
  • Wilson, G., Hebbard, L., Duan, W., George, J., Qiao, L. (2015). Editorial: Induced Pluripotent Stem Cells (iPSCs) in the Gastroenterology and Hepatology: from Basic Research to Clinical Applications. Current Stem Cell Research & Therapy. 10 (3) , 190-192.
  • Liu, X., Yang, Z., Chen, Z., Chen, R., Zhao, D., Zhou, Y., Qiao, L. (2015). Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells. Oncology Reports. 33 (1) , 157-162. [More Information]
  • Cheng, L., Zhang, Y., Nan, Y., Qiao, L. (2015). Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection. Current Stem Cell Research & Therapy. 10 (3) , 216-219.
  • Wu, G., Wilson, G., George, J., Qiao, L. (2015). Modulation of Notch Signaling as a Therapeutic Approach for Liver Cancer. Current Gene Therapy. 15 (2) , 171-181.
  • Wu, G., Wilson, G., Zhou, G., Hebbard, L., George, J., Qiao, L. (2015). Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma. Discovery Medicine. 20 (110) , 219-229.
  • Sun, C., Wilson, G., Fan, J., Qiao, L. (2015). Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in Hepatology Research. Current Stem Cell Research & Therapy. 10 (3) , 208-215.
  • Liu, S., Zhang, D., Chen, Y., Wang, B., Qiao, L. (2015). Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Gastrointestinal Disorders. Current Stem Cell Research & Therapy. 10 (3) , 220-227.
  • Sun, C., Fan, J., Qiao, L. (2015). Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 16 (3) , 5161-5179. [More Information]
  • Gao, J., Qiao, L., Wang, B. (2015). Primary Biliary Cirrhosis Is a Generalized Autoimmune Epithelitis. International Journal of Molecular Sciences. 16 (3) , 6432-6446. [More Information]
  • Zhang, L., Li, Y., Qiao, L., Zhao, Y., Wei, Y., Li, Y. (2015). Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells. International Journal of Oncology. 47 (2) , 632-640. [More Information]
  • Meng, W., Bai, B., Sheng, L., Li, Y., Yue, P., Li, X., Qiao, L. (2015). Role of helicobacter pylori in gastric cancer: Advances and controversies. Discovery Medicine. 20 (111) , 285-293.
  • Zhang, L., Song, X., Mohri, Y., Qiao, L. (2015). Role of Inflammation and Tumor Microenvironment in the Development of Gastrointestinal Cancers: What Induced Pluripotent Stem Cells Can Do?. Current Stem Cell Research & Therapy. 10 (3) , 245-250.
  • Zhang, Q., Zhou, D., Lei, Y., Zheng, L., Chen, S., Gou, H., Gu, Q., He, X., Lan, T., Qi, C., Qiao, L., et al (2015). Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway. Oncotarget. 6 (5) , 3123-3135.
  • Zhou, G., Wilson, G., George, J., Qiao, L. (2015). Targeting cancer stem cells as a therapeutic approach in liver cancer. Current Gene Therapy. 15 (2) , 161-170.
  • Charrez, B., Qiao, L., Hebbard, L. (2015). The role of fructose in metabolism and cancer. Hormone Molecular Biology and Clinical Investigation. 22 (2) , 79-89. [More Information]
  • Wu, F., Wang, J., Pu, C., Qiao, L., Jiang, C. (2015). Wilson’s Disease: A Comprehensive Review of the Molecular Mechanisms. International Journal of Molecular Sciences. 16 (3) , 6419-6431. [More Information]
  • Wu, F., Wang, J., Pu, C., Qiao, L., Jiang, C. (2015). Wilson's Disease: A Comprehensive Review of the Molecular Mechanisms. International Journal of Molecular Sciences. 16 (3) , 6419-6431. [More Information]

2014
  • Chen, X., Liu, H., Li, M., Qiao, L. (2014). Advances in non-surgical management of primary liver cancer. World Journal of Gastroenterology. 20 (44) , 16630-16638. [More Information]
  • Qiao, L. (2014). Cancer Letters special issue inflammation andgastrointestinal and liver cancers featuring the guest editor. Cancer Letters. 345 (2) , 149-149. [More Information]
  • O'Connor, M., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Qiao, L., Duan, W. (2014). Cancer stem cells: A contentious hypothesis now moving forward. Cancer Letters. 344 (2) , 180-187. [More Information]

    Show 14 more
  • Zang, S., Liu, T., Shi, J., Qiao, L. (2014). Curcumin: a promising agent targeting cancer stem cells. Anti-Cancer Agents in Medicinal Chemistry. 14 (6) , 787-792. [More Information]
  • Peng, M., Huang, B., Zhang, Q., Fu, S., Wang, D., Cheng, X., Wu, X., Xue, Z., Zhang, L., Zhang, D., Qiao, L., et al (2014). Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells. Cancer Letters. 354 (2) , 407-416. [More Information]
  • Dai, Y., Jiao, H., Teng, G., Wang, W., Zhang, R., Wang, Y., Hebbard, L., George, J., Qiao, L. (2014). Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 Signaling. Molecular Cancer Therapeutics. 13 (5) , 1206-1216. [More Information]
  • Cao, H., Zhu, K., Fan, J., Qiao, L. (2014). Garlic-Derived Allyl Sulfides in Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 14 (6) , 793-799. [More Information]
  • Wang, F., Meng, W., Wang, B., Qiao, L. (2014). Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Letters. 345 (2) , 196-202. [More Information]
  • Xu, C., Zhou, W., Wang, Y., Qiao, L. (2014). Hepatitis B virus-induced hepatocellular carcinoma. Cancer Letters. 345 (2) , 216-222. [More Information]
  • Duan, X., Qin, P., Yan, S., Ding, W., Fan, J., Qiao, L. (2014). High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. BMC Gastroenterology. 14 (1) , 1-10. [More Information]
  • Lin, J., Shigdar, S., Fang, D., Xiang, D., Wei, M., Danks, A., Kong, L., Li, L., Qiao, L., Duan, W. (2014). Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model. PloS One. 9 (7) , 1-13. [More Information]
  • Duan, X., Zhang, L., Fan, J., Qiao, L. (2014). NAFLD leads to liver cancer: Do we have sufficient evidence?. Cancer Letters. 345 (2) , 230-234. [More Information]
  • Zhou, W., Zhang, Q., Qiao, L. (2014). Pathogenesis of liver cirrhosis. World Journal of Gastroenterology. 20 (23) , 7312-7324. [More Information]
  • Qiao, L., Li, X. (2014). Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now. Cancer Letters. 1168 , 207-225. [More Information]
  • Dai, Y., Wilson, G., Huang, B., Peng, M., Teng, G., Zhang, D., Zhang, R., Ebert, M., Chen, J., Wong, B., George, J., Qiao, L., et al (2014). Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death and Disease. 5 , 1-9. [More Information]
  • Tian, A., Wilson, G., Lie, S., Wu, G., Hu, Z., Hebbard, L., Duan, W., George, J., Qiao, L. (2014). Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells. Cancer Letters. 351 (2) , 232-241. [More Information]
  • Peng, M., Xu, S., Zhang, Y., Zhang, L., Huang, B., Fu, S., Xue, Z., Da, Y., Dai, Y., Qiao, L., et al (2014). Thermosensitive injectable hydrogel enhances the antitumor effect of embelin in mouse hepatocellular carcinoma. Journal of Pharmaceutical Sciences. 103 (3) , 965-973. [More Information]

2013
  • Shigdar, S., Macdonald, J., O'Connor, M., Wang, T., Xiang, D., Al.Shamaileh, H., Qiao, L., Wei, M., Zhou, S., Zhu, Y., et al (2013). Aptamers as theranostic agents: Modifications, serum stability and functionalisation. Sensors. 13 (10) , 13624-13637. [More Information]
  • Chen, Z., Liu, M., Liu, X., Huang, S., Li, L., Song, B., Li, H., Ren, Q., Zenan, H., Zhou, Y., Qiao, L. (2013). COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. International Journal of Molecular Medicine. 32 (1) , 93-100. [More Information]
  • Wilson, G., Hu, Z., Duan, W., Tian, A., Wang, X., McCleod, D., Lam, V., George, J., Qiao, L. (2013). Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterising Liver Cancer Stem Cells. Stem Cells and Development. 22 (19) , 2655-2664. [More Information]

    Show 7 more
  • Wang, Y., Li, Y., Li, X., Liu, T., Liu, X., Zhang, J., Guo, J., Guo, L., Qiao, L. (2013). Hypermethylation of TGF-beta1 gene promoter in gastric cancer. World Journal of Gastroenterology. 19 (33) , 5557-5564. [More Information]
  • Liu, X., Chen, Z., Li, H., Hu, Z., Liu, M., Tian, A., Zhao, D., Wu, J., Zhou, Y., Qiao, L. (2013). Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells. World Journal of Gastroenterology. 19 (37) , 6265-6271. [More Information]
  • Hu, Z., Liu, X., Tang, Z., Zhou, Y., Qiao, L. (2013). Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer. Oncology Reports. 29 (3) , 993-1000. [More Information]
  • Pu, C., Wang, B., Qiao, L., Pu, C. (2013). Recent progress in research of biomarkers of acute kidney injury in liver cirrhosis. Zhonghua Ganzangbing Zazhi. 21 (10) , 796-798.
  • Shigdar, S., Qiao, L., Zhou, S., Xiang, D., Wang, T., Li, Y., Lim, L., Kong, L., Li, L., Duan, W. (2013). RNA aptamers targeting cancer stem cell marker CD133. Cancer Letters. 330 (1) , 84-95. [More Information]
  • Wilson, G., Tian, A., Hebbard, L., Duan, W., George, J., Li, X., Qiao, L. (2013). Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro. Cancer Letters. 341 (2) , 224-230. [More Information]
  • Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters. 330 (1) , 1-10. [More Information]

2012
  • Tian, A., Qiao, L., Yan, X. (2012). Aging and Hepatocellular Carcinoma: Possible Molecular Mechanisms. Molecular Aspects of Hepatocellular Carcinoma. , 80-85.
  • Liu, Q., Zhou, Y., Hu, Z., Qiao, L. (2012). An Overview on Molecular Therapy for Hepatocellular Carcinoma. Molecular Aspects of Hepatocellular Carcinoma. , 138-148.
  • Wang, F., Wang, B., Qiao, L. (2012). Association between obesity and gallbladder cancer. Frontiers in Bioscience. 17 , 2550-2558. [More Information]

    Show 8 more
  • Duan, X., Qiao, L., Fan, J. (2012). Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International. 11 (1) , 18-27. [More Information]
  • Qiao, L., Li, Y., Yan, X., George, J. (2012). Molecular Aspects of Hepatocellular Carcinoma. Molecular Aspects of Hepatocellular Carcinoma.
  • Guo, L., Li, Y., Qiao, L., Liu, T., Du, Y., Zhang, J., He, W., Zhao, Y., He, D. (2012). Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. World Journal of Gastroenterology. 18 (48) , 7262-7270. [More Information]
  • Li, Q., Zhang, J., Zhou, Y., Qiao, L. (2012). Obesity and gastric cancer. Frontiers in Bioscience. 17 (7) , 2383-2390. [More Information]
  • Shen, C., Zhao, C., Zhang, R., Qiao, L. (2012). Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. Frontiers in Bioscience. 17 (6) , 2356-2370. [More Information]
  • Li, Z., Chim, J., Yang, M., Ye, J., Wong, B., Qiao, L. (2012). Role of PCDH10 and its hypermethylation in human gastric cancer. BBA: Biochimica et Biophysica Acta - Molecular Cell Research. 1823 (2) , 298-305. [More Information]
  • Jiang, X., Huang, K., Yang, M., Qiao, L., Wang, Q., Ye, J., Zhou, H., Yi, Z., Wu, F., Wang, Z., et al (2012). Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-kB pathways. Cancer Letters. 326 (2) , 135-142. [More Information]
  • Zhao, C., Liu, X., Shen, C., Wang, Y., Qiao, L. (2012). Treatment of Hepatocellular Carcinoma with Traditional Chinese Medicine: Possible Molecular Mechanisms. Molecular Aspects of Hepatocellular Carcinoma. , 167-173.

2011
  • Wu, J., Lu, H., Ling, X., Wang, C., Rui, J., Wang, A., Qiao, L. (2011). {2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D-Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line. Medical Oncology: a leading journal in clinical oncology. 28 (4) , 986-990.
  • Li, Z., Chen, J., Chan, K., Qiao, L., Wong, B. (2011). A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Letters. 313 (2) , 192-200. [More Information]
  • Liu, S., Wah Chan, K., Tong, J., Wang, Y., Wang, B., Qiao, L. (2011). PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellular carcinoma: a case report and a summary of recent literature. QJM: Quarterly Journal of Medicine. 104 (6) , 477-483. [More Information]

2010
  • Zhou, Y., Li, G., Wu, J., Zhang, Z., Wu, Z., Fan, P., Hao, T., Zhang, X., Li, M., Zhang, F., Qiao, L., et al (2010). Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumor Biology. 31 (6) , 549-558. [More Information]
  • Ye, J., Chan, G., Qiao, L., Lian, Q., Meng, F., Luo, X., Khachigian, L., Ma, M., Deng, R., Chen, J., et al (2010). Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway. Haematologica. 95 (10) , 1745-1753. [More Information]

2009
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Zhang, R., Ma, J., Zou, B., Lam, C., Wang, J., et al (2009). Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer. Molecular Cancer Therapeutics. 8 (9) , 2762-2770. [More Information]
  • Liu, S., Chan, K., Wang, B., Qiao, L. (2009). Fibrolamellar Hepatocellular Carcinoma. American Journal of Gastroenterology. 104 (10) , 2617-2624. [More Information]
  • Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan, S., Qiao, L., Jiang, B., Tu, S., et al (2009). Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer. Carcinogenesis. 30 (9) , 1507-1516. [More Information]

    Show 3 more
  • Wang, J., Gu, Q., Li, M., Zhang, W., Yang, M., Zou, B., Chan, S., Qiao, L., Jiang, B., Tu, S., et al (2009). Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer.. Carcinogenesis. 30 (9) , 1507-1516. [More Information]
  • Dai, Y., Qiao, L., Chan, K., Yang, M., Ye, J., Ma, J., Zou, B., Gu, Q., Wang, J., Lan, H., et al (2009). Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Research. 69 (11) , 4776-4783. [More Information]
  • Qiao, L., Wong, B. (2009). Role of Notch signaling in colorectal cancer. Carcinogenesis. 30 (12) , 1979-1986. [More Information]

2008
  • Wu, J., Ren, D., Zhou, Y., Zhang, Z., Zhang, Z., Yan, X., Wang, Q., Wang, Z., Wang, H., Zhang, J., et al (2008). A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Letters. 269 (1) , 18-25. [More Information]
  • Ma, J., Yang, X., Qiao, L., Liang, L., Chen, M. (2008). CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy. Journal of Digestive Diseases. 9 (2) , 79-83. [More Information]

2006
  • Qiao, L., Zhang, H., Yu, J., Francisco, R., Dent, P., Ebert, M., Röcken, C., Farrell, G. (2006). Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role.. Human Gene Therapy. 17 (3) , 280-290.
  • Hsu, M., Qiao, L., Ho, V., Zhang, B., Zhang, H., Teoh, N., Dent, P., Farrell, G. (2006). Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats.. Journal of Hepatology. 44 (2) , 375-382. [More Information]
  • Yu, J., Qiao, L., Zimmermann, L., Ebert, M., Zhang, H., Lin, W., Röcken, C., Malfertheiner, P., Farrell, G. (2006). Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.. Hepatology. 43 (1) , 134-143.

2005
  • Wu, J., Qi, D., Wei, K., Li, J., Chen, X., Wang, A., liu, W., Xue, Q., Qiao, L. (2005). 2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells.. Experimental Oncology. 27 (1) , 52-55.
  • Farrell, G., Hou, J., Zhang, H., Francisco, R., Nan, Y., Osvath, S., Qiao, L., Dela Pena, A., Sedger, L. (2005). Apoptosis occurs early and involves trail receptors, while hepatocellular proliferation is delayed but vigorous in a murine dietary model of steatohepatitis. 56th Annual Meeting of the American Association for the Study of Liver Diseases. 42 , 632A-632A.
  • Wu, J., Kou, W., Gao, M., Zubal, G., Wang, A., Xue, Q., Qiao, L. (2005). Effects of {2-(3-carboxy-1-oxoprogy 1)amino-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line.. Acta Pharmacologica Sinica. 26 (5) , 635-640.

    Show 2 more
  • Qiao, L., Yu, J., Dent, P., Farrell, G. (2005). NF-kappaB Protects Rat ARL-6 Hepatocellular Carcinoma Cells Against Hydrogen Peroxide-Induced Apoptosis.. Cancer Biology and Therapy. 4 (11) , 1195-1202.
  • Liu, Q., Ma, K., He, Z., Dong, J., Hua, X., Huang, X., Qiao, L. (2005). Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: A pilot study.. Journal of Gastrointestinal Surgery. 9 (5) , 648-657.